Search Results - "Olaru, ID"

Evaluation of weight‐based prescription of antiretroviral therapy in children by Dakshina, S, Olaru, ID, Khan, P, Raman, L, McHugh, G, Bwakura–Dangarembizi, M, Nathoo, K, Munyati, S, Mujuru, H, Ferrand, RA

“…Objectives The aim of the study was to investigate the extent of and factors associated with incorrect dosing of antiretroviral therapy (ART) in HIV‐infected…”
Get full text

What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi- and Extensively Drug-Resistant Tuberculosis by Heyckendorf, Jan, Andres, Sönke, Köser, Claudio U, Olaru, Ioana D, Schön, Thomas, Sturegård, Erik, Beckert, Patrick, Schleusener, Viola, Kohl, Thomas A, Hillemann, Doris, Moradigaravand, Danesh, Parkhill, Julian, Peacock, Sharon J, Niemann, Stefan, Lange, Christoph, Merker, Matthias

“…Rapid and accurate drug susceptibility testing (DST) is essential for the treatment of multi- and extensively drug-resistant tuberculosis (M/XDR-TB). We…”
Get full text

Implications of antibiotic exposure among children in low-income and middle-income countries by Olaru, Ioana D, Kibuule, Dan, Godman, Brian

Get full text

Personalized medicine for patients with MDR-TB by Olaru, Ioana D, Lange, Christoph, Heyckendorf, Jan

“…The emergence of MDR-TB is a cause of great concern due to difficulties in patient management and poor treatment outcomes. Currently the duration of treatment…”
Get full text

Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe by Lange, Christoph, Duarte, Raquel, Fréchet-Jachym, Mathilde, Guenther, Gunar, Guglielmetti, Lorenzo, Olaru, Ioana D, Oliveira, Olena, Rumetshofer, Rudolf, Veziris, Nicolas, van Leth, Frank

Get full text

Novel drugs against tuberculosis: a clinician's perspective by Olaru, Ioana Diana, von Groote-Bidlingmaier, Florian, Heyckendorf, Jan, Yew, Wing Wai, Lange, Christoph, Chang, Kwok Chiu

“…The United Nations Millennium Development Goal of reversing the global spread of tuberculosis by 2015 has been offset by the rampant re-emergence of…”
Get full text

Multidrug-resistant tuberculosis and migration to Europe by Hargreaves, S., Lönnroth, K., Nellums, L.B., Olaru, I.D., Nathavitharana, R.R., Norredam, M., Friedland, J.S.

“…Multidrug-resistant tuberculosis (MDR-TB) in low-incidence countries in Europe is more prevalent among migrants than the native population. The impact of the…”
Get full text

Bedaquiline-based treatment regimen for multidrug-resistant tuberculosis by Olaru, Ioana D, Heyckendorf, Jan, Andres, Sönke, Kalsdorf, Barbara, Lange, Christoph

“…Treatment outcomes for multidrug-resistant (MDR) tuberculosis (TB) are poor with only approximately 50% of patients attaining treatment success [1]. An…”
Get full text

Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model by Heyckendorf, Jan, Marwitz, Sebastian, Reimann, Maja, Avsar, Korkut, DiNardo, Andrew, Günther, Gunar, Hoelscher, Michael, Ibraim, Elmira, Kalsdorf, Barbara, Kaufmann, Stefan H E, Kontsevaya, Irina, van Leth, Frank, Mandalakas, Anna Maria, Maurer, Florian P, Müller, Marius, Nitschkowski, Dörte, Olaru, Ioana D, Popa, Cristina, Rachow, Andrea, Rolling, Thierry, Rybniker, Jan, Salzer, Helmut J F, Sanchez-Carballo, Patricia, Schuhmann, Maren, Schaub, Dagmar, Spinu, Victor, Suárez, Isabelle, Terhalle, Elena, Unnewehr, Markus, Weiner, 3rd, January, Goldmann, Torsten, Lange, Christoph

“…The World Health Organization recommends standardised treatment durations for patients with tuberculosis. We identified and validated a host-RNA signature as a…”
Get full text

Rapid diagnosis of pulmonary tuberculosis by combined molecular and immunological methods by Jafari, Claudia, Olaru, Ioana D, Daduna, Franziska, Ernst, Martin, Heyckendorf, Jan, Lange, Christoph, Kalsdorf, Barbara

“…Diagnosing pulmonary tuberculosis (TB) may be delayed until culture results become available.We ascertained the accuracy of a stepwise diagnostic algorithm for…”
Get full text

Getting Personal Perspectives on Individualized Treatment Duration in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis by HEYCKENDORF, Jan, OLARU, Ioana D, RUHWALD, Morten, LANGE, Christoph

“…Tuberculosis (TB) differs from most other bacterial infectious diseases by a very long duration of combination antibiotic therapy required to achieve…”
Get full text

Fixed dose drug combinations - are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries by Godman, Brian, McCabe, Holly, D Leong, Trudy

“…: There are positive aspects regarding the prescribing of fixed dose combinations (FDCs) versus prescribing the medicines separately. However, these have to be…”
Get more information

Time to culture positivity and sputum smear microscopy during tuberculosis therapy by Olaru, Ioana D, Heyckendorf, Jan, Grossmann, Susanne, Lange, Christoph

“…Sputum smear microscopy is widely used for tuberculosis diagnosis and treatment monitoring. We evaluated the correlation between smear microscopy and time to…”
Get full text

Assessment of antimicrobial use and prescribing practices among pediatric inpatients in Zimbabwe by Olaru, Ioana D., Meierkord, Anne, Godman, Brian, Ngwenya, Crispen, Fitzgerald, Felicity, Dondo, Vongai, Ferrand, Rashida A., Kranzer, Katharina

“…This study aims to assess antimicrobial consumption in the pediatric department of a tertiary care public hospital in Zimbabwe. Clinical records of pediatric…”
Get full text

Revisiting Healthcare Workers as a Risk Group for Progression toward Tuberculosis by Olaru, Ioana D, Lange, Christoph, Sester, Martina

Get full text

High Rates of Treatment Success in Pulmonary Multidrug-Resistant Tuberculosis by Individually Tailored Treatment Regimens by Olaru, Ioana D, Lange, Christoph, Indra, Alexander, Meidlinger, Liliya, Huhulescu, Steliana, Rumetshofer, Rudolf

“…We evaluated whether treatment outcomes for patients with multidrug-resistant and extensively drug-resistant tuberculosis can be substantially improved when…”
Get full text

Relapse-free cure from multidrug-resistant tuberculosis in Germany by Heyckendorf, Jan, van Leth, Frank, Kalsdorf, Barbara, Olaru, Ioana D, Günther, Gunar, Salzer, Helmut J F, Terhalle, Elena, Rolling, Thierry, Glattki, Georg, Müller, Marius, Schuhmann, Maren, Avsar, Korkut, Lange, Christoph

“…Multidrug-resistant (MDR) tuberculosis (TB), defined by bacillary resistance against rifampicin and isoniazid, has been identified as a global threat to…”
Get full text

Attitudes about tuberculosis prevention in the elimination phase: a survey among physicians in Germany by Gutsfeld, Christian, Olaru, Ioana D, Vollrath, Oliver, Lange, Christoph

“…Targeted and stringent measures of tuberculosis prevention are necessary to achieve the goal of tuberculosis elimination in countries of low tuberculosis…”
Get full text

Reply to Dookie et al., "Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis" by Köser, Claudio U, Heyckendorf, Jan, Andres, Sönke, Olaru, Ioana D, Schön, Thomas, Sturegård, Erik, Beckert, Patrick, Schleusener, Viola, Kohl, Thomas A, Hillemann, Doris, Moradigaravand, Danesh, Parkhill, Julian, Peacock, Sharon J, Niemann, Stefan, Lange, Christoph, Merker, Matthias

Get full text

Treatment responses in multidrug-resistant tuberculosis in Germany by Heyckendorf, J., van Leth, F., Avsar, K., Glattki, G., Günther, G., Kalsdorf, B., Müller, M., Olaru, I. D., Rolling, T., Salzer, H. J. F., Schuhmann, M., Terhalle, E., Lange, C.

“…BACKGROUND: Excellent treatment outcomes have recently been reported for patients with multi/extensively drug-resistant tuberculosis (M/XDR-TB) in settings…”
Get full text